XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]  
Disaggregation of revenue
The following table represents Evolent’s revenue disaggregated by segment and end-market for the three and nine months ended September 30, 2021 and 2020 (in thousands):
For the Three Months Ended September 30,For the Nine Months Ended September 30,
20212020202120202021202020212020
Evolent Health ServicesClinical SolutionsEvolent Health ServicesClinical Solutions
Medicaid$41,857 $51,637 $51,829 $73,480 $154,850 $165,584 $148,816 $197,992 
Medicare4,816 28,483 91,249 63,663 19,500 57,729 267,793 190,223 
Commercial and other30,154 19,830 2,566 2,479 62,177 59,535 6,463 7,040 
Total$76,827 $99,950 $145,644 $139,622 $236,527 $282,848 $423,072 $395,255 
Contract with customer, asset and liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of September 30, 2021 and December 31, 2020 (in thousands):
September 30, 2021
December
31, 2020 (1)
Short-term receivables (2)
$172,171 $122,167 
Long-term receivables (2)
4,796 4,554 
Short-term contract assets— 329 
Short-term deferred revenue13,785 10,187 
Long-term deferred revenue4,457 3,593 
————————
(1)Amounts exclude $3.4 million of short-term receivables and $4.1 million of short-term deferred revenue reclassified to discontinued operations as of December 31, 2020.
(2)Excludes pharmacy claims receivable and premiums receivable

Changes in deferred revenue for the nine months ended September 30, 2021 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$13,780 
Reclassification to revenue, as a result of performance obligations satisfied(9,343)
Cash received in advance of satisfaction of performance obligations13,805 
Balance as of end of period$18,242